Current Event 

Short Courses
Business of BioBanking 

Science of BioBanking

BioBanking Brainstorming Breakthroughs
PDF Download 
Hotel & Travel
Sponsorship/ Exhibits
Press Pass 
Request Brochure 



Please click here to download the following podcasts: 

Developing Global Quality Controls and Standards

Realistic and Cost-Effective Strategies to Extend ‘Next-Tech Assays’ to Tissue Samples 

Clinical Focus Tech Guide
Clinical Focus Technical Guide
A Troubleshooting Guide: Experts Share Their
Advice on FFPE, qpcr, and Multivariate Biomarkers

Courtesy of GenomeWeb

Random DNA Fragmentation Whitepaper
Random DNA fragmentation
allows detection of... more>>>

Transitioning a Biobanking Effort with Scientific and Fiscal Responsibility

2009 Presentation Highlights 

Scientific & Technical Considerations for Developing & Managing Biobanking Protocols Short Course 




Bio-IT World

Genetic Engineering News


Science AAAS logo

The Scientist


Genome Technology


Genomeweb Logo

Pharm Cast

SelectScience logo


Conference Proceeding CD Now Available
  • Speaker Presentations
  • Poster Abstracts
  • and More!

Molecular advances in biomedical science require high-quality biospecimens (tissue, body fluid, or other material) which provide macromolecules (DNA/RNA, proteins, enzymes, etc.) that are used for diagnostic, therapeutic, and epidemiologic purposes, allowing researchers to better link molecular and clinical information. Today, biospecimen collections are used by multiple groups for varying aims from basic research through clinical trials. Investigators realize that the proper collection, processing, storage, and tracking of biospecimens are critical components of biomarker-related studies.

Thus, by necessity, biobanking is both a science and a business; therefore, BioBanking: Maximizing Your Investment focuses on both angles.

The Business of BioBanking

As biobank repositories grow, the pressure increases for standardization, documentation, protocols, and preservation procedures to efficiently produce the best quality product. In addition, “omics” has complicated the direction of biomedical research, and those managers involved must now negotiate the regulatory, ethical, and legal issues involved in the preservation and use of biospecimens.

Who Should Attend:

Directors, heads, and managers of:

  • Biobanks
  • Tissue banks
  • Biorepositories


Click here to download brochure 

The Science of BioBanking

Recent advances in molecular high-throughput assays have intensified the need for well annotated, properly preserved biospecimens. A thorough assay often requires samples from both diseased/treated and normal/untreated tissue. The Science of BioBanking addresses methodologies that maximize the quality and utility of biospecimens for biomarker research.

Who Should Attend:

Research scientists working with:

  • Biospecimens
  • Biomarkers
  • Bioextraction
  • Biopreservation


Click here to download brochure 

By Series:
By Region: